AriBio Licenses Exclusive Marketing Rights for AR1001 for Alzheimer's Disease in China for $770 Million USD | Nation/World
SEONGNAM-SI, South Korea--(BUSINESS WIRE)--Mar 24, 2024--
Source: bdtonline.com
Samjin Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Samjin Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Samjin Pharmaceutical Today - Breaking & Trending Today
Treat-to-Target or High-Intensity Statin in Clinical CAD?
Some patients with side-effect concerns aiming to lessen their statin burden may prefer the treat-to-target approach, if they respond well to lesser-intensity statins, say researchers.
Source: medscape.com
Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease
This randomized clinical trial compares the efficacy of a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy of 50 to 70 mg/dL as the goal vs
Source: jamanetwork.com
Florentijn Hofman's NFT Artwork To Be Launched by ARKPIA
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com